Postoperative pain after prosthetic breast augmentation
Conditions
Interventions
the control group:1.5 ml of 0.9% saline was used for each injection area
the ropivacaine group:1.5 ml of 0.75% ropivacaine was used for each injection area
the ropivacaine+methylene blue group:1.5 ml of 0.75% ropivacaine/1% methylene blue mixture (10 ml of 0.75% ropivacaine + 2 ml of 1% methylene solution) was used for each injection area
Sponsors
Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) aged between 18 and 70 years old; (2) wish and plan to undergo prosthetic breast augmentation; (3) ASA I-III, tolerance to general anesthesia; (4) fully comprehend medical condition and voluntarily participate; (5) mentally normal
Exclusion criteria
Exclusion criteria: (1) signs of infection in the injection area; (2) history of allergy to local anesthetics, morphine or methylene blue; (3) injection threatening prosthesis; (4) coagulopathy (5) chronic pain syndromes; (6) patients or their family refuses to sign consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| flatulence;dizziness;nausea;vomiting;insomnia; fatigue;cough;dyspnea;anxiety;depression;urinary retention;Bleeding/hematoma;Pneumothorax;Nerve injury;Neuritis;Anesthetic toxicity;Allergy;Block site infection; | — |
Countries
China
Contacts
Public ContactTongtong Zhang
Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed